Medical News

RSS

Valeant's board approves $1.5 billion securities repurchase program

Valeant Pharmaceuticals International, Inc. today announced that it may make purchases of its convertible notes, senior notes and/or common shares under a $1.5 billion securities repurchase program (collectively, the "Securities Repurchase Program") approved by Valeant's Board of Directors.

4 Nov 2010

Novel serum test may help diagnose early pregnancy location and outcome

Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). In the western world, deaths from ectopic pregnancy are not common but in the developing world one in ten women who are admitted with an ectopic pregnancy die.

4 Nov 2010

PDI announces acquisition of Group DCA

PDI, Inc., a leading provider of integrated promotional outsource services to health care companies, today announced the expansion of its business with the acquisition of Group DCA, a privately held interactive digital communications agency serving biopharmaceutical companies. Excluding transaction costs, PDI expects the acquisition to be cash flow positive immediately and accretive to earnings in 2011.

4 Nov 2010

Inspire third quarter net loss decreases to $7.6 million

Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2010, reporting a net loss of $7.6 million or ($0.09) per share, an improvement from the third quarter of 2009 during which the Company incurred a net loss of $8.5 million or ($0.12) per share.

4 Nov 2010

Most kidney care providers opt to participate in new Medicare 'bundled' payment system: Study

The Kidney Care Council (KCC), a nonprofit national health care association composed of leading kidney dialysis provider companies who care for a majority of ESRD patients nationwide, released new data today revealing that 98 percent of kidney care providers participating in a recent study have opted to participate in the new Medicare "bundled" payment system in January 2011, more than twice the rate originally anticipated.

4 Nov 2010

Benchmark adds Class III medical device manufacturing capabilities in Thailand

Benchmark Electronics, Inc., a leading integrated electronics manufacturing services (EMS) provider, announced its Thailand facility has successfully completed a full Quality System Inspection Technique (QSIT) audit from the Food and Drug Administration (FDA), through its premarket approval (PMA) supplement evaluation process, to manufacture Class III finished devices on behalf of large tier-one medical original equipment manufacturers (OEMs).

4 Nov 2010

Agilent announces solution for exon analysis based on SurePrint G3 Exon Microarrays

Agilent Technologies Inc. today announced a solution for exon analysis based on SurePrint G3 Exon Microarrays. The solution provides a major expansion of Agilent's portfolio of gene expression reagents, microarrays and bioinformatics systems. This new system, available in mid-November, enables researchers to examine alternately expressed exons according to recently updated content, providing a global picture of RNA expression.

4 Nov 2010

'Phantom' images brain keeps for visual comparisons stored in brain's neural network

Brain research over the past 30 years has shown that if a part of the brain controlling movement or sensation or language is lost because of a stroke or injury, other parts of the brain can take over the lost function - often as well as the region that was lost.

4 Nov 2010

SandlotConnect attains 1.5 million patient records to provide HIE in Texas

Sandlot, LLC, a healthcare IT solutions company founded by practicing physicians who have pursued a better way to collectively share clinical information, announced that its comprehensive health information exchange (HIE) SandlotConnect now contains more than 1.5 million patient records, allowing providers to access and contribute to the largest HIE in Texas.

4 Nov 2010

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT(R) (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.

4 Nov 2010

Volunteering benefits older adults with functional limitations

Volunteering is known to provide health benefits to the person doing the volunteering. Now, a new study finds that older adults with functional limitations (trouble conducting daily tasks like cooking meals) in particular appear to reap the benefits from helping others.

4 Nov 2010

Experts develop tools to educate people about health risks associated with global travel

More than 30 million people in the United States travel to resource-limited areas of the world each year. This global mobility may contribute to the spread of infectious diseases such as influenza, measles, and meningitis and may also put individual travelers at risk for malaria, typhoid, dengue fever and hepatitis.

4 Nov 2010

Pfizer's two new compounds may be effective in treating alcohol, nicotine dependence

Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.

4 Nov 2010

NextGen Inpatient Clinicals version 2.4 earns CCHIT Certified 2011 Inpatient EHR designation

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Inpatient Clinicals version 2.4 has earned designation as a premarket conditionally CCHIT Certified® 2011 Inpatient EHR.

4 Nov 2010

Novel drug-coated balloon technology adopted in niche applications across Europe: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, novel drug-coated balloon technology is being adopted in niche applications throughout Europe. This market will continue to grow as physicians increasingly use the technology in cases where other devices may not be suitable.

4 Nov 2010

Kidney disease registry could help clinicians to evaluate treatment strategies for CKD patients

A registry of health care information on patients with mild to moderate chronic kidney disease (CKD) could help physicians improve care for affected individuals, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that officials could use such a registry to develop a national surveillance system to identify and track various aspects of CKD.

4 Nov 2010

RF Surgical introduces new RF Assure Detection platform

RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the availability of the RF Assure™ Detection System Model 200.

4 Nov 2010

NormOxys' OXY111A candidate selected as ‘Top 10 to Watch’ at Windhover's meeting

NormOxys Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues and organs, today announced that OXY111A, its clinical stage candidate for the treatment of chronic heart failure and cancer, has been selected as one of Windover's "Top 10 Cardiovascular/Metabolic Projects to Watch."

4 Nov 2010

Patient share of Actemra for RA to exceed patient share for Cimzia and Simponi, says Report

Bio-Trends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis Q3 2010. This report covers the use of biologics for the treatment of rheumatoid arthritis (RA). The report, part of a quarterly series, focuses on current and future use of biologic agents, patient market share, perceived strengths and weaknesses of the key brands, barriers to broader usage, sales force performance and perceived value of manufacturers' patient assistance programs.

4 Nov 2010

New findings on mitochondrial haplogroups associated with successful aging to be presented at ASHG Meeting

Thousands of the world's top scientists and clinicians in the human genetics field will convene to present their latest research findings at the American Society of Human Genetics (ASHG) 60th Annual Meeting, on November 2-6, 2010, in Washington, D.C.

4 Nov 2010

Medical News

Valeant's board approves $1.5 billion securities repurchase program

Novel serum test may help diagnose early pregnancy location and outcome

PDI announces acquisition of Group DCA

Inspire third quarter net loss decreases to $7.6 million

Most kidney care providers opt to participate in new Medicare 'bundled' payment system: Study

Benchmark adds Class III medical device manufacturing capabilities in Thailand

Agilent announces solution for exon analysis based on SurePrint G3 Exon Microarrays

'Phantom' images brain keeps for visual comparisons stored in brain's neural network

SandlotConnect attains 1.5 million patient records to provide HIE in Texas

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

Volunteering benefits older adults with functional limitations

Experts develop tools to educate people about health risks associated with global travel

Pfizer's two new compounds may be effective in treating alcohol, nicotine dependence

NextGen Inpatient Clinicals version 2.4 earns CCHIT Certified 2011 Inpatient EHR designation

Novel drug-coated balloon technology adopted in niche applications across Europe: MRG

Kidney disease registry could help clinicians to evaluate treatment strategies for CKD patients

RF Surgical introduces new RF Assure Detection platform

NormOxys' OXY111A candidate selected as ‘Top 10 to Watch’ at Windhover's meeting

Patient share of Actemra for RA to exceed patient share for Cimzia and Simponi, says Report

New findings on mitochondrial haplogroups associated with successful aging to be presented at ASHG Meeting

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News